nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aptamer-functionalized liposomes for targeted cancer therapy
|
Moosavian, Seyedeh Alia |
|
2019 |
448 |
C |
p. 144-154 |
artikel |
2 |
Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
|
Fu, Shengling |
|
2019 |
448 |
C |
p. 11-19 |
artikel |
3 |
Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma
|
Wang, Rong |
|
2019 |
448 |
C |
p. 84-93 |
artikel |
4 |
Diabetes and cancer: Debating the link through Ca2+/cAMP signalling
|
Bergantin, Leandro Bueno |
|
2019 |
448 |
C |
p. 128-131 |
artikel |
5 |
3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2
|
Tian, Xueli |
|
2019 |
448 |
C |
p. 20-30 |
artikel |
6 |
Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy
|
Liu, Mengrui |
|
2019 |
448 |
C |
p. 31-39 |
artikel |
7 |
Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer
|
He, Qiang |
|
2019 |
448 |
C |
p. 94-104 |
artikel |
8 |
Editorial Board
|
|
|
2019 |
448 |
C |
p. ii |
artikel |
9 |
Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells
|
Elliott, Bethtrice |
|
2019 |
448 |
C |
p. 155-167 |
artikel |
10 |
Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy
|
Liang, Kang |
|
2019 |
448 |
C |
p. 168-181 |
artikel |
11 |
Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma
|
Huang, Deng |
|
2019 |
448 |
C |
p. 117-127 |
artikel |
12 |
Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer
|
Nikhil, Kumar |
|
2019 |
448 |
C |
p. 182-196 |
artikel |
13 |
Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells
|
Fellenberg, J. |
|
2019 |
448 |
C |
p. 61-69 |
artikel |
14 |
Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation
|
Tian, Jingyan |
|
2019 |
448 |
C |
p. 1-10 |
artikel |
15 |
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation
|
Hillert, Ellin-Kristina |
|
2019 |
448 |
C |
p. 70-83 |
artikel |
16 |
Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression
|
Yu, Le |
|
2019 |
448 |
C |
p. 40-51 |
artikel |
17 |
Targeted demethylation of the SARI promotor impairs colon tumour growth
|
Wang, Qin |
|
2019 |
448 |
C |
p. 132-143 |
artikel |
18 |
USP26 promotes esophageal squamous cell carcinoma metastasis through stabilizing Snail
|
Li, Lei |
|
2019 |
448 |
C |
p. 52-60 |
artikel |
19 |
ZBTB7A, a miR-663a target gene, protects osteosarcoma from endoplasmic reticulum stress-induced apoptosis by suppressing LncRNA GAS5 expression
|
Zhang, Lu |
|
2019 |
448 |
C |
p. 105-116 |
artikel |